Sarah Hickman
Director, Human Resources & Administration
- Role
- Director Human Resources Administration at Adjuvance Technologies, Inc
- Location
- Lincoln, NE, US
- LinkedIn followers
- 500 followers
About Sarah Hickman
HR professional with more than 2 decades experience working in Fortune 500 organizations, not-for-profits, mutual-companies and venture backed start-ups. In that time, I\'ve held roles of responsibility as a people leader and individual contributor and possess a skilled and diverse background in human resources management, recruiting, and consulting in a variety of industries. I hold extensive experience in all disciplines of Human Resources, corporate wide project management, building HR infrastructures in newly developed organizations and regional experience covering multiple facilities.
Experience
Director Human Resources Administration
Apr 2020 — Present · Lincoln, NE, US
In my role, at Adjuvance, I am a member of the management team. I have supported rapid scale up and expansion of the organization by fully partnering with cross-functional leaders and the c-suite to find balanced solutions that meet the needs of the business and support our core values. I have built, defined, and elevated the HR function as a strategic partner. Specific responsibilities include talent attraction and retention, workforce planning, culture, total rewards, employee relations, talent management, compensation, benefits, payroll, safety, and policy deployment. I love what I do!Adjuvance Technologies is a privately-held, clinical-stage biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in adjuvant design, vaccine development, and manufacturing. Adjuvance creates and manufactures next generation proprietary adjuvants as the foundation of its vaccine pipeline and for other developers through licensing partnerships. The next generation semi-synthetic saponin adjuvants are used to prevent and treat infectious diseases, and in immuno-oncology, neurobiology, substance abuse, and allergy. Our first adjuvant, TQL-1055, has increased vaccine immunogenicity and favorable tolerability in a clinical trial. Our vaccine candidates in pertussis and herpes zoster aim to provide a better experience for the recipient and the same protection against disease
Education
Bellevue University
Master of Science - MS, Stategic Human Resources Management
2017 — 2018
Nebraska Wesleyan University
Bachelor's degree, Political Science/Women's Studies
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.